TLR2 and TLR4 expression after kidney ischemia and reperfusion injury in mice treated with FTY720


Autoria(s): PEDREGOSA, J. F.; HAIDAR, A. A.; HIRATA, A. E.; FRANCO, M.; GOMES, G. N.; BUENO, V.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

20/10/2012

20/10/2012

2011

Resumo

Ischemia and reperfusion injury (IR) is an antigen independent inflammatory process that causes tissue damage. After IR, kidneys up-regulate leukocyte adhesion molecules and toll-like receptors (TLRs). Moreover, injured kidneys can also secrete factors (i.e. heat shock protein) which bind to TLRs and trigger intracellular events culminating with the increase in the gene expression of inflammatory cytokines. FTY720 is an immunomodulatory compound and protects at least in part kidneys submitted to IR. The mechanisms associated with FTY720`s beneficial effects on kidneys after IR remain elusive. We investigated whether FTY720 administration in mice submitted to kidney IR is associated with modulation of TLR2 and TLR4 expression. C57BL/6 mice submitted to 30 min of renal pedicles clamp were evaluated for serum parameters (creatinine, urea and nitric oxide), kidney histology, spleen and kidney infiltrating cells expression of TLR2 and TLR4, resident kidney cells expression of TLR2 and TLR4 and IL-6 protein expression in kidney. FTY720-treated mice presented decrease in serum creatinine, urea and nitric oxide, diminished expression of TLR2 and TLR4 both in spleen and kidney infiltrating cells, and reduced kidney IL-6 protein expression in comparison with IR non-treated mice. However, acute tubular necrosis was present both in IR non-treated and IR + FTY720-treated groups. Also, FTY720 did not prevent TLR2 and TLR4 expression in kidney resident cells. In conclusion, FTY720 can promote kidney function recovery after IR by reducing the inflammatory process. Further studies are needed in order to establish whether TLR2 and TLR4 down regulation should be therapeutically addressed as protective targets of renal function and structure after IR. (C) 2011 Elsevier B.V. All rights reserved.

Identificador

INTERNATIONAL IMMUNOPHARMACOLOGY, v.11, n.9, p.1311-1318, 2011

1567-5769

http://producao.usp.br/handle/BDPI/28673

10.1016/j.intimp.2011.04.014

http://dx.doi.org/10.1016/j.intimp.2011.04.014

Idioma(s)

eng

Publicador

ELSEVIER SCIENCE BV

Relação

International Immunopharmacology

Direitos

restrictedAccess

Copyright ELSEVIER SCIENCE BV

Palavras-Chave #Kidney #Ischemia and reperfusion #FTY720 #Toll-like receptors #Nitric oxide #IL-6 #ACUTE-RENAL-FAILURE #ISCHEMIA/REPERFUSION INJURY #RECEPTOR #PATHWAYS #TRANSPLANTATION #INFLAMMATION #RESPONSES #Immunology #Pharmacology & Pharmacy
Tipo

article

original article

publishedVersion